Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4884 USD | +3.61% | -1.39% | -61.24% |
Mar. 11 | BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities | CI |
Mar. 04 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 25.88M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-
| Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.72% |
1 day | +3.61% | ||
1 week | -1.39% | ||
Current month | -7.60% | ||
1 month | -24.43% | ||
3 months | -60.61% | ||
6 months | -84.59% | ||
Current year | -61.24% |
Managers | Title | Age | Since |
---|---|---|---|
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 16-04-10 |
Joanne Kim
DFI | Director of Finance/CFO | 59 | 18-09-30 |
Joseph Palumbo
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Gorlin
BRD | Director/Board Member | 87 | 20-06-15 |
Richard Berman
BRD | Director/Board Member | 81 | 19-06-23 |
Jim Lang
CHM | Chairman | 59 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 0.4884 | +3.61% | 1,381,402 |
24-04-17 | 0.4714 | -3.40% | 610,796 |
24-04-16 | 0.488 | -0.95% | 319,244 |
24-04-15 | 0.4927 | -3.49% | 1,846,700 |
24-04-12 | 0.5105 | +3.07% | 1,063,465 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.24% | 25.88M | |
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.84% | 13.78B | |
+0.59% | 13.4B | |
+20.86% | 11.06B |
- Stock Market
- Equities
- BIVI Stock